Sun biopharma, inc. changes name to panbela therapeutics inc.

Minneapolis, dec. 01, 2020 (globe newswire) -- sun biopharma, inc. (nasdaq: snbp), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with cancer, has announced the change of its corporate name to panbela therapeutics, inc. effective december 2, 2020. the company's trading symbol will also change from snbp to pbla at the opening of the markets on december 2, 2020. as a result of the change, the cusip number for the company's common stock will also change to 69833q100. stockholders are not required to exchange their existing share certificates or warrants for new certificates or warrants bearing the new name. the name change does not affect the company's capital structure or the rights of the company's stockholders, and no action is required by existing stockholders.
PBLA Ratings Summary
PBLA Quant Ranking